Ledger.Open graph →
SEC Form D · filed June 19, 2012

IZUN PHARMACEUTICALS CORP

Offering
—
Sold
$4.1M
Exemption
—
Industry
Pharmaceuticals
Location
JERUSALEM, L3
Type
—

People & firms on this filing (8)

William Z. Levine · Jerusalem, L3Exec · DirectorBenjamin Jesselson · Jerusalem, L3DirectorWilliam Z. Levine · Jerusalem, L3Exec · DirectorYarom Oren · Jerusalem, L3DirectorBenjamin Jesselson · San Francisco, CADirectorAron Saffer · Beit Shemesh, L3Exec · DirectorHersch Cooper · Jerusalem, L3DirectorAvner Rotman · Rehovot, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗